1017608-20-6 Usage
Description
4-Iodo-3-isopropylphenol is a chemical compound characterized by its molecular formula C9H11IO and a molecular weight of 280.08 g/mol. It presents as a white to light yellow powder with a distinct strong phenolic odor.
Uses
Used in Organic Synthesis:
4-Iodo-3-isopropylphenol is utilized as an intermediate in organic synthesis, playing a crucial role in the creation of various complex organic molecules.
Used in Pharmaceutical Production:
4-Iodo-3-isopropylphenol is employed in the production of a range of pharmaceuticals and fine chemicals, contributing to the development of new medications and chemical products.
Used as Antiseptic and Disinfectant:
4-Iodo-3-isopropylphenol is used for its antimicrobial properties, serving as an antiseptic and disinfectant in various applications to prevent infection and maintain cleanliness.
Used in Cosmetics Industry:
With potential applications in the cosmetics field, 4-Iodo-3-isopropylphenol is incorporated as an ingredient in personal care products, enhancing their efficacy and quality.
Safety Note:
It is important to handle 4-Iodo-3-isopropylphenol with care due to its toxic nature. It poses risks if swallowed or inhaled and can cause skin and eye irritation, necessitating proper safety measures during its use and disposal.
Check Digit Verification of cas no
The CAS Registry Mumber 1017608-20-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,1,7,6,0 and 8 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1017608-20:
(9*1)+(8*0)+(7*1)+(6*7)+(5*6)+(4*0)+(3*8)+(2*2)+(1*0)=116
116 % 10 = 6
So 1017608-20-6 is a valid CAS Registry Number.
1017608-20-6Relevant articles and documents
SUBSTITUTED-N-HETEROARYL COMPOUNDS AND USES THEREOF
-
Page/Page column 125, (2020/01/24)
The present disclosure relates generally to compounds useful for the treatment and/or enhancement of cognitive function and negative symptoms associated with central nervous system disorders where the circuitry involving fast spiking PV+ interneurons and the production of cortical gamma oscillations is disrupted. The subject disclosure enables the manufacture of medicaments as well as compositions containing same for use in methods of therapy and prophylaxis of cognitive dysfunction and negative symptoms.
Toward proteomimetics: Terphenyl derivatives as structural and functional mimics of extended regions of an α-helix [18]
Orner,Ernst,Hamilton
, p. 5382 - 5383 (2007/10/03)
-
